INTRODUCTION {#S1}
============

Dual RNA sequencing (RNA-seq) is emerging as a powerful new tool that is of particular value in the dissection of the host-pathogen interplay, revealing the impact both organisms exert over each other. The majority of studies published to date have involved tissue culture models of infection conducted on cell lines or on differentiated primary cells. Although clearly of considerable value, these studies do not address the *in vivo* host cell heterogeneity that for many pathogens is central to the control or progression of the infection. This is of particular significance for pathogens such as *Mycobacterium tuberculosis* (Mtb), for which bacterial survival and growth are linked to the ontogeny and metabolism of the different macrophage lineages that co-exist in the tuberculosis granuloma ([@R28]). Dual RNA-seq would be ideally suited to determining the molecular dynamics underlying host cell phenotype and bacterial fitness among these divergent host cell lineages ([@R67]), but the challenges in generating dual RNA-seq datasets from *in vivo* material in which bacterial burden is low and variable, and host cell heterogeneity is high, remain daunting.

Studies undertaking dual RNA-seq on *in vivo* samples have been performed on total tissues rich in extracellular bacteria, such as *Yersinia pseudotuberculosis*-infected lymph nodes ([@R51]), *Pseudomonas aeruginosa*-infected lung tissue ([@R18]), *Mycobacterium leprae*-infected human tissue lesions ([@R47]), and *Toxoplasma gondii*-infected brain tissue ([@R57]). Application of dual-RNA-seq to *in vivo* infected cell populations is in development. In particular, a new pipeline called Path-seq was recently used to recover the Mtb transcriptome from alveolar macrophages (AMs) isolated from the murine lung ([@R56]); however, the majority of datasets in the study came from *in vitro* infections.

Recently we used an acute mouse Mtb challenge model with fluorescent Mtb fitness reporter strains ([@R77]; [@R78]) to demonstrate that bacteria in the resident AMs from the lung displayed lower stress and greater rates of replication relative to bacteria within recruited, monocyte-derived interstitial macrophages (IMs) ([@R28]). In the present study we sought to determine the host and bacterial transcriptomes associated with the different Mtb growth phenotypes ([@R28]). We performed dual RNA-seq on Mtb-infected AM and IM host cell populations isolated directly from mouse lungs. Using a modified RNA extraction protocol, together with a data analysis pipeline tailored for samples with low sequencing depth, we were able to enrich for bacterial transcripts and increase the resolution of differential gene expression (DGE). Analysis of the datasets provides novel insights into the host cell conditions that Mtb has to endure during infection of lung macrophages *in vivo*. Finally, the increased resolution provided by probing the transcriptomes of both host and pathogen emphasizes the significance of the metabolic interface in supporting bacterial growth in permissive host macrophages and restricting bacterial growth in controller host cells.

RESULTS {#S2}
=======

Physical Enrichment of Bacterial RNA from Total RNA in Mtb-Infected Lung Macrophages {#S3}
------------------------------------------------------------------------------------

In this work we sought to develop a streamlined RNA extraction protocol to perform *in vivo* dual RNA-seq on Mtb-infected lung macrophage sub-populations. We focused on an *in vivo* single time point, 14 days post-infection (p.i.), which enabled us to discriminate between the functional phenotypes of the resident AMs and the recruited, blood monocyte-derived IMs ([@R28]).

Our protocol ([Figure 1B](#F1){ref-type="fig"}) is based on the differential lysis of the host and Mtb cells in Trizol/GTC. The first step involved incubation in Trizol of the sorted infected cells at room temperature (RT). This allowed complete lysis of the host cell and release of the eukaryotic RNA and intracellular bacteria. The sample was centrifuged to pellet eukaryotic cell debris and Mtb. In step 2, up to 90% of the Trizol supernatant containing the bulk of the eukaryotic RNA was separated from the pelleted Mtb and set to one side. This step achieved two goals: leaving a small amount of Trizol in the tube avoided disturbing the bacterial pellet and meant that the host RNA was not subjected to the harsh Mtb homogenization treatment ([Figure 1C](#F1){ref-type="fig"}). In step 3, zirconia beads and fresh Trizol were added to the tube containing the bacteria, which were subjected to mechanical lysis. In step 4, we added back part of the Trizol containing the host-RNA supernatant. This step enriched bacterial transcripts while enabling sufficient recovery of total RNA for library preparation. In [Figure 1D](#F1){ref-type="fig"} we show the relative percentage of Mtb reads recovered using preliminary optimization tissue culture test samples following the removal of differing amounts of host RNA. These were compared with the percentage of Mtb reads that were obtained from the AM and IM populations from each of the three independent *in vivo* experiments ([Figure 1D](#F1){ref-type="fig"}; [Table 1](#T1){ref-type="table"}). The results confirm the value of this approach to manually enrich bacterial transcripts.

Assessment of Different Statistical Methods for Analysis of Depth-Constrained Dual RNA-Seq Transcriptomes {#S4}
---------------------------------------------------------------------------------------------------------

The relative abundance of bacterial and host reads indicated that we achieved between 0.3% and 2% of mapped reads for Mtb from the different host populations across the three *in vivo* experiments ([Table 1](#T1){ref-type="table"}). We therefore decided to target a sequencing depth of \~1 M reads for the Mtb transcriptome from our *in vivo* samples, and we sought to determine the best statistical approach for analysis of our datasets that have constrained sequencing depth. Recently, a new empirical Bayes procedure (APEGLM) has been shown to be particularly robust in ranking genes by log fold change (LFC) in the presence of low counts ([@R89]). Therefore, we tested whether this statistical procedure could also provide superior results in the analysis of our dual RNA-seq datasets with constrained read counts.

Using our Mtb reference datasets ([Figure S1](#SD1){ref-type="supplementary-material"}) that have been sequenced to saturation ([Table 1](#T1){ref-type="table"}) and a range of different statistical approaches for RNA-seq analysis (edgeR \[[@R62]\], limma-voom \[[@R38]; [@R61]\], DESeq2 \[[@R41]\], IHW \[[@R29]\], Cuffdiff \[[@R79]\], and APEGLM \[[@R89]\]), we performed DGE analysis on the full datasets and on five independent, randomly sampled subsets of 1 M reads ([Figure S2A](#SD1){ref-type="supplementary-material"}). We defined the differentially expressed genes using edgeR, limma-voom, DESeq2, and IHW on the full datasets as the most robust set of differentially expressed genes for analysis, nominally defined as the "true DE" ([Figure 1E](#F1){ref-type="fig"}). We then compared the performance of the various methods on the randomly sampled subsets against this consensus list and found APEGLM to have an average power of 80.88% ([Figure S2B](#SD1){ref-type="supplementary-material"}) and an average false-positive rate of 3.5%, which was considerably more robust than the other approaches ([Figure 1F](#F1){ref-type="fig"}). Therefore, all subsequent DGE analysis was carried out using DESeq2 and APEGLM as the means of determination of the change in expression between datasets. The data analysis pipeline is illustrated in [Figure S1](#SD1){ref-type="supplementary-material"} and provided in [STAR Methods](#S11){ref-type="sec"}.

Identification of an Mtb *In Vivo* Transcriptional Signature in Mice {#S5}
--------------------------------------------------------------------

Exploratory analysis of our *in vivo* dual RNA-seq datasets for the Mtb transcriptome revealed the presence of transcriptional signatures distinct to each of the four different environmental conditions ([Figure 2A](#F2){ref-type="fig"}; [Table S3](#SD2){ref-type="supplementary-material"}). To identify those genes that were upregulated only by Mtb *in vivo*, we focused on transcripts (abs\[log~2~ FC \> 1\], adjusted p \< 0.05) whose expression was upregulated in one or both host macrophage populations (IMs and AMs) but not upregulated in either short-term bone marrow-derived macrophage (BMDM) or broth culture conditions. We found 274 genes that satisfied these requirements. However, in previous microarray studies, [@R73] defined a differential intraphagosomal transcriptome (454 genes induced in resting and activated BMDMs at 24 and 48 h p.i.), while [@R65] determined the transcriptional profile of Mtb during an extended period of infection (up to 14 days) in BMDMs. Our BMDM dataset was restricted to an early time point (6 h p.i.); therefore, to encompass a broader range of cell culture conditions, we mined the data from these earlier studies (see [STAR Methods](#S11){ref-type="sec"}) to ensure a more robust means of identifying gene signatures unique to the *in vivo* infection environment. The comparison of the 274 genes from the present study with the genes identified as upregulated in BMDMs in these earlier studies identified 180 genes uniquely upregulated in macrophages *in vivo* ([Figure 2B](#F2){ref-type="fig"}; [Table S4](#SD3){ref-type="supplementary-material"}). We nominally defined this set of genes as the "*in vivo* signature."

The assignment of function to the genes identified as upregulated in Mtb *in vivo* was pursued using pathway and protein-protein network analysis ([Figures 2C](#F2){ref-type="fig"} and [2D](#F2){ref-type="fig"}). The pathways specifically upregulated by Mtb during the course of an *in vivo* infection were linked predominantly to cholesterol homeostasis, nitrogen assimilation, nitric oxide (NO) detoxification, and protein and lipid export machinery ([Figure 2D](#F2){ref-type="fig"}). It is notable that all 15 genes within the Kstr2 regulon were strongly upregulated during *in vivo* infection by Mtb in both IMs and AMs ([Figure 2E](#F2){ref-type="fig"}), suggesting that cholesterol is degraded completely to support bacterial survival in mice. This is consistent with data from both genetic analysis and chemical screening ([@R10]; [@R82]). We know from previous work that cholesterol degradation leads to expansion of the propionyl-CoA pool, which induces metabolic stress on Mtb ([@R39]; [@R48]; [@R71]). However, although detoxification of the propionyl-CoA pool through the methyl citrate cycle (MCC) is required for growth of *Mtb* in macrophages in culture, it was the methyl-malonyl pathway (MMP), leading to the synthesis of Mtb cell wall lipids, that appeared to be the preferred routing of propionyl-CoA *in vivo* ([Figure 2F](#F2){ref-type="fig"}). Indeed, genes involved in the synthesis and transport of the cell wall phthiocerol dimycocerosates (PDIMs) were also upregulated *in vivo* specifically (*fadD26, ppsA-ppsE, mmpL7*, and *Rv2943*) ([Figure S3A](#SD1){ref-type="supplementary-material"}).

A cluster of high-confidence interactions for nodes (genes) related to nitrate/nitrite assimilation and ergothioneine (EGT) biosynthesis pathways was present in our network, suggesting that these processes may be integrated during lung macrophage infection. Genes required for inorganic nitrogen assimilation ([Figure 2G](#F2){ref-type="fig"}) were highly expressed by Mtb in both host cell types and were implicated in either nitrate/nitrite detoxification through generation of ammonia (*nirB, nirD, Rv0818, narX, narK2*, and *narK3*) ([@R43]) or ammonia uptake (*amt, glnB*, and *glnD*) ([@R58]; [@R86]). Increased intracellular levels of ammonia are essential for glutamate production, and glutamate dehydrogenase (*gdh*) has been shown to be indispensable for growth on glutamate or related amino acids (glutamine, aspartate) as limiting carbon sources in the presence of NO ([@R25]). Looking at possible organic nitrogen sources, our dataset revealed upregulation of genes linked to the import of amino acids that can easily be converted to glutamate: *proX, proZ, proW*, and *proV* (glycine betaine transport), *gabP* (arginine and GABA), *rv0072* and *rv0073* (glutamine), and *rocE* (ornithine) ([Figure S3B](#SD1){ref-type="supplementary-material"}). Glutamate, together with cysteine, is also the substrate of *egtA*, the enzyme of the EGT pathway responsible for the production of the end product γ-glutamyl cysteine, that has been shown to be required in the detoxification of reactive oxidative and nitrosative species in Mtb. A knockout (KO) mutant of *egtA* led to a 4 log~10~ reduction in bacterial burden in mice infection ([@R68]; [@R70]). Intriguingly, although all the genes of the EGT biosynthetic pathway were upregulated in our *in vivo* datasets, the magnitude of this response differed between the two host macrophage lineages, with the induction being elevated in IMs ([Figure 2L](#F2){ref-type="fig"}), which are known to present a more hostile intracellular environment with increased levels of NO ([@R28]) ([Figure 5C](#F5){ref-type="fig"}). Therefore, in lung macrophages, generation of glutamate appears to be a link between detoxification of NO via EGT biosynthesis and nitrogen metabolism for energy production. EGT genes ([Figure S3C](#SD1){ref-type="supplementary-material"}) are regulated by the 4Fe-4S cluster DNA-binding protein WhiB3, which maintains redox homeostasis ([@R16]). WhiB3 also regulates expression of the molybdate transport system *modA, modB, modC*, which was also highly expressed *in vivo* ([Figure S4B](#SD1){ref-type="supplementary-material"}), providing an additional rationale for the significance of nitrogen assimilation and metabolism in supporting Mtb growth in a reducing environment ([@R15]).

Previous work has shown that the ESX-5 secretion system enhances bacterial virulence *in vivo*, although the specific mechanism(s) involved are undefined ([@R8]; [@R72]). The *Esx-5* locus is thought to be regulated by the Pst/SenX3-RegX3 transcriptional regulatory system that responds to inorganic phosphate limitation ([@R20], [@R21]). Although we did not specifically observe upregulation of the genes involved in response to phosphate starvation (data not shown), we note that genes encoding the subunits of the transporter were highly upregulated *in vivo*, with the induction being more prominent for Mtb in IMs ([Figures 2H](#F2){ref-type="fig"} and [S4A](#SD1){ref-type="supplementary-material"}). This differential expression is consistent with reports demonstrating that IL-1β and inflammasome activation via NALP3 is dependent on a functional ESX-5 secretion system ([@R1]). Our data from the host transcriptome analysis reinforce this conclusion, as both the inflammasome and IL-1β pathways were more strongly upregulated in the IM lineage ([Figure S3C](#SD1){ref-type="supplementary-material"}).

Analysis of Different Host-Pathogen Transcriptional Patterns in Mtb-Infected and Uninfected AMs and IMs {#S6}
-------------------------------------------------------------------------------------------------------

PCA analysis of the mouse transcripts ([Figure 3D](#F3){ref-type="fig"}) shows a very clear separation between ontologically linked host responses (PC1) and infection-associated responses (PC2). In previous studies we had found that the resident AM lineage was more supportive of bacterial growth than the blood monocyte-derived IM lineage ([@R28]). Therefore, in this work we sought to identify those ontology-specific responses involved in the differential growth dynamics reported previously. In order to generate a detailed appreciation of the transcriptional differences between the two host cell lineages, we directly compared both bacterial and host RNA-seq profiles in infected AMs versus IMs. A total of 319 Mtb genes (223 up in IMs, 96 up in AMs, adjusted p \< 0.05) were found to be differentially expressed between the two bacterial populations ([Figure 3A](#F3){ref-type="fig"}; [Table S3](#SD2){ref-type="supplementary-material"}), while among the host cell transcripts 3,732 genes were differentially expressed in IMs compared with AMs, and 4,097 genes in AMs compared with IMs, with adjusted p \< 0.05 ([Figure 3B](#F3){ref-type="fig"}; [Table S5](#SD4){ref-type="supplementary-material"}).

In order to identify host transcriptional signatures specific to infection versus those associated with macrophage ontogeny, we also performed DGE analysis on bystander, uninfected macrophage populations recovered from Mtb-infected mouse lungs. In summary, within the bystander cell populations, 4,707 genes were upregulated in IMs and 4,035 genes in AMs, with adjusted p \< 0.05 ([Table S5](#SD4){ref-type="supplementary-material"}). Furthermore, to identify the ontogenically specific responses to Mtb infection, we also compared the transcriptional profiles of infected and uninfected cells in each macrophage subset. In AMs, 3,453 genes were upregulated and 3,119 downregulated following infection ([Table S5](#SD4){ref-type="supplementary-material"}), while in IMs, 3,614 genes were upregulated and 3,298 genes downregulated (adjusted p \< 0.05) ([Table S5](#SD4){ref-type="supplementary-material"}).

To acquire greater insights into the biological processes of significance that characterize each macrophage subtype and their infection status, we performed gene set enrichment analysis (GSEA) on the ranked lists of genes ([@R45]) and scored \~26,000 gene sets for enrichment in each of our transcriptional comparisons. When considering the infected populations, a total of 205 gene sets were enriched in IMs and 375 in AMs (p \< 0.01), while among the uninfected cells, 201 and 236 gene sets were enriched, respectively (p \< 0.01). As previously stated, we also analyzed the transcriptional differences between infected and uninfected populations in each macrophage subtype: for AMs, 156 gene sets were enriched in the infected population and 161 in the uninfected one (p \< 0.01), while for IMs, 109 and 63 were enriched for each population, respectively (p \< 0.01). From this GSEA we then constructed network enrichment maps ([@R60]) to provide a broad overview of the main biological themes associated with each host cell lineage and infection condition ([Figures 3E](#F3){ref-type="fig"}, [4B](#F4){ref-type="fig"}, [5B](#F5){ref-type="fig"}, and [S5](#SD1){ref-type="supplementary-material"}).

Identification of Host and Bacterial Transcriptional Responses in Mtb Growth-Permissive AMs {#S7}
-------------------------------------------------------------------------------------------

The enrichment maps that compare the two different macrophage ontologies ([Figures 3E](#F3){ref-type="fig"} and [S5](#SD1){ref-type="supplementary-material"}) show marked upregulation of genes associated with pathways related to cell division (E2F targets, DNA replication, microtubule reorganization, mitotic spindle, and G/M checkpoints), fatty acid metabolism, oxidative phosphorylation, and mitochondrial function in both the infected and uninfected resident AM populations, therefore indicating an ontogeny-specific metabolic bias for this population of host cells.

Research into macrophage immune function has revealed a linkage between fatty acid metabolism and an optimal response to type I interferon ([@R87]), a pathway that is well known to promote *Mtb* pathogenesis ([@R44]). Intriguingly, the enrichment maps for AM showed upregulation of pathways related to triglyceride and cholesterol metabolic processes. In-depth analysis of the most highly expressed genes associated with these pathways revealed a small subset in AM ([Figure 4A](#F4){ref-type="fig"}), most specifically *Mgl*, a monoacylglycerol lipase that hydrolyzes intracellular triglyceride stores to free fatty acids and glycerol; *Lpl*, a lipoprotein lipase that completes hydrolysis of monoglycerides from degradation of lipoprotein triglycerides; *LipA*, lysosomal acid lipase, the primary enzyme that hydrolyzes cholesteryl esters derived from low-density lipoprotein (LDL); 7-dehydrocholesterol (7-DHC) reductase (*Dhcr7*), which converts 7-DHC to cholesterol; the peroxisome proliferator-activated receptor gamma (Ppar-γ), which regulates lipid uptake; and *Lpin1*, the co-activator of PPAR-γ, which encodes an enzyme that catalyzes the penultimate step in triglyceride synthesis and is involved in lipid sequestration and foamy macrophage formation. This clear metabolic shift to cholesterol and fatty acid metabolism is consistent with previous data that linked the metabolic state of the AM population with the enhanced growth phenotype observed for Mtb in these cells *in vivo* ([@R28]).

Analysis of the pathways upregulated by AM following infection ([Figure 4B](#F4){ref-type="fig"}) unveiled a small gene network involved in response to oxidative stress. Recent work by [@R66] revealed that at early time points (up to 10 days p.i.), an NRF2-mediated oxidative stress response is upregulated in AM-infected cells compared with bystander and naive macrophages, and overexpression of the NRF2 signature is associated with reduced pro-inflammatory responses and impaired control of bacterial growth. Our data agree with these findings, as we show that at 14 days p.i., the same NRF2 pathway is upregulated in infected AMs ([Figure 4C](#F4){ref-type="fig"}), while pro-inflammatory cytokines ([Figure S6](#SD1){ref-type="supplementary-material"}) and molecules needed to prevent inflammation-associated intracellular damage are expressed at lower levels than infected IMs ([Figure 4E](#F4){ref-type="fig"}). Among the pathways that are downregulated in AMs following infection are those related to oxidative phosphorylation, cholesterol, and fatty acid biosynthesis, but the levels of expression of the genes in these pathways remain higher than in IMs ([Figure S4C](#SD1){ref-type="supplementary-material"}).

We used the Seahorse Extracellular Flux analyzer to examine the cell metabolism of AMs and IMs isolated from Mtb-infected mouse lungs as an independent validation for our RNA-seq analysis. Consistently, AMs exhibited much higher basal and maximal oxygen consumption rates (OCRs) compared with IMs, indicating the engagement of oxidative phosphorylation and mitochondrial activities ([Figure 4DI](#F4){ref-type="fig"}). Notably, AMs also revealed a higher spare respiratory capacity (SRC) ([Figure 4DII](#F4){ref-type="fig"}). Last, the maximal OCR in AM was reduced to the basal level after inhibition of the fatty acid oxidation pathway with etomoxir (Eto), whereas Eto had no effect on OCR in IMs ([Figures 4DI](#F4){ref-type="fig"} and [4DIII](#F4){ref-type="fig"}), indicating that AMs are engaged in fatty acid oxidation. This observed disparity between the mitochondrial activity in AMs and IMs validates the RNA-seq data indicating that fatty acid metabolism is more active in AMs.

These results support the contention that at 14 days p.i., the infected AMs represent a host cellular niche more permissive for bacterial growth, an interpretation also supported by the transcriptional profile of Mtb isolated from AMs. These bacteria exhibited clear upregulation of several genes known to be involved in cell division and growth (*ftsK, sepF, cdpC, rv1215c, ripA*, and *ripD*), ribosomal protein synthesis (*fusA1, rpsG, tuf, rpmG2, ppiA*, and *ppiB*), and cell wall synthesis and remodeling (*embB, rv0648, rv3258c*, and *fbpC*) ([Figure 5AI](#F5){ref-type="fig"}). Moreover, *sigD* and the anti-sigma factor SigD *rv3413c*, which had previously been shown to modulate the expression of ribosomal genes, were also upregulated ([Figure 5AII](#F5){ref-type="fig"}) ([@R9]). In addition, in context with the AM host cell transcriptional profile indicating an abundance of free fatty acids, glycerol, and triglycerides, the bacterial transcriptome showed upregulation of genes known to be involved in fatty acid import (*mce1A, mce1B, mce1C*, and *mce1F*) ([@R49], [@R50]), mycolic acid biosynthesis (*hadA, hadB*, and *hadC*), lipid degradation (*rv1075c, lipU, plcB*, and *plcC*), and TCA cycle and β oxidation (*acn, rv0111, icl2, fixA, icd2, echA8*, and *accE5*) ([Figures 4A](#F4){ref-type="fig"} and [5AI](#F5){ref-type="fig"}), suggesting that fatty acid oxidation may be the preferred route of energy production for growth of *Mtb* in the AM lineage.

Pro-inflammatory Host Gene Signatures in IMs Are Associated with an Enhanced Mtb Bacterial Stress Response {#S8}
----------------------------------------------------------------------------------------------------------

Transcriptional profiling of both infected and uninfected IM populations revealed a marked induction of pro-inflammatory pathways such as NF-κB activation and Th1 immune response (IL-1β, TNF-α, and IFN-γ) ([Figures 3E](#F3){ref-type="fig"} and [S5](#SD1){ref-type="supplementary-material"}). Interestingly, one of the most robust networks upregulated in these cells are those genes associated with adhesion and chemotaxis, in agreement with the demonstration that this host cell population is recruited to the granuloma site from the peripheral blood ([@R28]). Looking at pathways differentially expressed upon infection ([Figure 5B](#F5){ref-type="fig"}), IMs showed marked upregulation of gene sets related to ubiquitination, NO and reactive oxygen species (ROS) biosynthesis, secreted factors, glycolysis, and inflammatory responses. In addition, pathways related to potassium and chloride transport, two inorganic ions necessary for Mtb survival ([@R42]; [@R78]), were downregulated. These host cell signatures are consistent with the IM lineage's posing a much harsher environment for Mtb. The data indicate that monocyte-derived macrophages, recruited to the site of infection from the blood, are already activated toward a Th1 immune response potentially geared to contain Mtb growth.

Turning to the bacterium, analysis of the 226 genes upregulated by Mtb in the IM host cell population indicated that the bacterium copes with numerous different environmental stresses. Indeed, the *dosR* operon that mediates the transcriptional response of Mtb to oxygen limitation and NO ([@R6]) and whose induction is required by the bacteria to enter into a non-replicative state was upregulated (*dosT, dosR, dosS*, and *Rv3134c*) ([Figure 6AI](#F6){ref-type="fig"}). This is also consistent with the bacterial fitness reporter strain (*smyc'::mCherry;hspX'::gfp*), which has been shown to express higher GFP levels in IMs following a controlling immune response ([@R28]; [@R77]) that led to activation of a dosR regulon promoter element ([Figure 6AIII](#F6){ref-type="fig"}). The type II toxin-antitoxin-chaperon module *higA1-higB1-secB* that has been shown to be induced under stress conditions and hypothesized to be involved in bacterial persistence ([@R22]) was also upregulated, along with many genes related to DNA repair and protein folding ([Figure 6AII](#F6){ref-type="fig"}). Finally, while most of the genes in the "*in vivo* signature" are common to Mtb in both AMs and IMs, we do observe further elevation of expression of genes involved in EGT biosynthesis, molybdate transport, and nitrogen assimilation pathways by Mtb in IMs, consistent with the analysis of the mouse transcriptome from the infected cells, which reveals that both *Hif1A* (hypoxia inducible factor) and *Nos2* (NO synthase) are upregulated in this host cell population ([Figure 5C](#F5){ref-type="fig"}). These data suggest that host-derived NO and a reducing environment are significant environmental pressures encountered by Mtb in IMs.

Iron Metabolism Is a Prominent Transcriptional Signature Differentiating Mtb Infection in AMs and IMs {#S9}
-----------------------------------------------------------------------------------------------------

A robust transcriptional signature related to genes associated with iron metabolism was observed in both the host and pathogen ([Figure 6B](#F6){ref-type="fig"}). Specifically, AM-derived bacteria overexpressed genes associated with iron storage, suggesting that they are in an iron-replete environment. These bacteria upregulated expression of *BfrB* (ferritin), a storage protein essential for iron sequestration during oxidative stress conditions ([@R54]) and *Rv0452* a transcriptional repressor of the *mmpS4* and *mmpL4* siderophore exporter proteins involved in iron scavenging ([@R11]; [@R31]).

Conversely, IM-derived Mtb showed a transcriptional signature normally associated with low-iron conditions. Mtb synthesizes the Fe^3+^-specific siderophores mycobactin and carboxymycobactin to scavenge insoluble and the protein-bound iron directly from the host. Genes involved in carboxymycobactin synthesis are organized into two clusters, *mbt1* and *mbt2* ([@R35]), and both loci were strongly upregulated in Mtb isolated from IM ([Figure 6B](#F6){ref-type="fig"}). In addition, genes encoding the iron-regulated ABC transporter *IrtAB*, which is required for Fe^+3^-carboxymycobactin uptake, were also overexpressed ([@R63]). Recently, [@R80] described a new means of iron acquisition, heme-iron acquisition (HIA), and showed that PPE37, an iron-regulated PPE family member, was essential for HIA. PPE37 expression was strongly upregulated in Mtb in IMs, suggesting that this pathway of iron acquisition may also be important for Mtb survival in IMs *in vivo* ([Figure 6AIII](#F6){ref-type="fig"}). This is a broad transcriptional signature indicating that the bacteria in the IM host cell lineage are competing to acquire iron from their host, in marked contrast to the iron-replete environment that is experienced by Mtb in AMs.

Turning to the host, both macrophage subsets upregulated genes in a manner similar to the iron-response profiles reported for M1 versus M2 macrophages ([@R59]; [@R76]) ([Figure 6B](#F6){ref-type="fig"}). In IMs, which are restrictive for Mtb growth, one of the most highly differentially expressed genes was the transcriptional regulator Spi-C. Spi-C has been shown to be upregulated in a heme-dependent manner in splenic red pulp macrophages that are required to degrade senescent erythrocytes and recycle heme-associated iron ([@R27]). IMs also exhibited increased levels of expression of mRNA for Scara5, a ferritin-binding scavenger receptor ([@R40]), Trfc, the transferrin receptor, haptoglobin, which binds hemoglobin, and most significantly the intracellular iron transporter Nramp1 ([Figure 6C](#F6){ref-type="fig"}), which has been shown to control intracellular bacterial infections by limiting availability of divalent cations in the phagosome ([@R12]; [@R81]). C57BL/6 mice have a loss-of-function mutation in the Slc11a1 gene (*Nramp1*), associated with inability to clear some types of intracellular infections ([@R83]). However, this lesion does not affect the rate of import/export of iron from cells, indicating that it is part of a larger physiological program ([@R36]). The iron starvation phenotype observed by Mtb in IM supports the hypothesis that these genes are involved in the generation of an iron sequestration phenotype consistent with M1 macrophage activation and increased microbicidal activity ([@R23]).

In contrast, AMs exhibited enhanced expression of the transcription factor *Myc*, and ectopic expression of Myc has been shown to drive polarization of macrophages toward a M2-like phenotype ([@R55]; [@R88]), which is linked to iron release ([@R23]; [@R75]). As illustrated in [Figure 6B](#F6){ref-type="fig"}, AMs showed relatively higher levels of expression of transcripts for CD163, the hemoglobin scavenger receptor, Hrg1, the endosomal heme transporter, and Ngal, the lipocalin 2 receptor ([@R23]; [@R30]; [@R75]). In addition, they showed increased transcripts for Aco1/Irp1, the dual aconitase/cytosolic iron response protein that regulates transcription of several IRE-containing genes ([@R69]; [@R85]) including *Aco2*, the mitochondrial aconitase, *Fech*, ferrochelatase required for heme biosynthesis, *Hmox2*, a hemoxygenase involved in breakdown of heme and release of iron, and *Trf*, transferrin. Moreover, mRNAs encoding several iron-containing, iron-utilizing, and iron-regulating mitochondrial proteins were upregulated indicative of the enhanced mitochondrial activity know to occur in these cells (namely, *Fxn*, the mitochondrial iron regulator frataxin; *Alas1*, aminolevulinate synthase; *fdx1*, a mitochondrial electron transfer protein adrenodoxin; and *Sfxn1* & *2*, iron-regulated mitochondrial serine transporters) ([@R32]; [@R46]). This profile is consistent with the M2-like polarization profile and enhanced mitochondrial respiration of the AM population.

DISCUSSION {#S10}
==========

Successful execution of dual RNA-seq from *in vivo*-derived infected host cell populations remains a considerable technical challenge. However, in the present study we were able to generate robust datasets on both host and bacterium from two distinct host myeloid lineages isolated directly from infected mouse lungs using a simple bacterial RNA enrichment protocol. Moreover the use of fluorescent bacterial fitness reporter strains in an *in vivo* infection model that incorporates host cell heterogeneity and provides an adequate source of infected host cells for flow sorting and isolation increases the resolution of such studies ([@R67]). The data presented here detail the transcriptional responses of both host and pathogen during *in vivo* infection of two ontologically distinct macrophage lineages.

The dual RNA-seq datasets in this study provide further elucidation of why AMs represent a preferred niche for Mtb replication. The data are also consistent with IMs' being recruited to the site of infection and fulfilling the major role in the containment of bacterial growth. Previous work showed that depletion of the AM population resulted in an 80% reduction in bacterial burden, while depletion of IMs resulted in almost a 10-fold increase in bacterial burden ([@R28]). Our analysis of both host and bacterial transcriptomes re-emphasizes the significance of nutritional immunity ([@R34]) for *in vivo* control of infection. The key role played by iron metabolism in tuberculosis infection is not a new theme and is backed by an extensive body of data from genome-wide susceptibility studies ([@R24]; [@R26]; [@R83]) to experimental *in vitro* infections ([@R2]; [@R17]; [@R19]; [@R52], [@R53]; [@R84]). Moreover, many of the host genes involved in the iron transcriptional signature have been reported to be responsive to heme-associated iron, tempting one to speculate that the hemorrhaging and red blood cell damage, frequently observed in infected mouse tissue, may drive this aspect of the host cell response. This interpretation is consistent with a recent report that ferroptosis, or iron-mediated cell death, is a robust signature in Mtb-infected mouse lung tissue ([@R3]).

Finally, although both Mtb populations are shifted to cholesterol use *in vivo*, the Mtb in the AM population exhibits a more marked upregulation of genes involved in acquisition and use of fatty acids. Metabolic flux analysis of host macrophages provided experimental verification of the increased oxidative phosphorylation and mitochondrial function in AMs compared with IMs, providing further support that the growth advantage experienced by Mtb in AMs is also a consequence of the metabolic interface between host cell and pathogen.

In the present study we examine a single time point during mouse infection, and although such analysis needs to be extended to later time points following the development of acquired immunity, it holds considerable value as a proof of principle and technical advance that stresses the importance of interrogating *in vivo*-derived host cell and pathogen populations to unravel the molecular basis of infection and the disease process.

STAR★METHODS {#S11}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S12}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, David G. Russell (<dgr8@cornell.edu>).

This study did not generate new unique reagents. Plasmids used in this study will be available through contact information provided in the [Key Resources Table](#T2){ref-type="table"}.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S13}
--------------------------------------

### Mtb Strains {#S14}

*Mycobacterium tuberculosis* Erdman ATCC 35801 was the parental strain used for all experiments. The fluorescent reporter *smyc'::mCherry* was previously described ([@R77]). Bacteria were grown at 37°C to mid-log phase in MiddleBrook 7H9 broth supplemented with 10% oleic acid/albumin/dextrose/catalase (OADC Enrichment - Becton, Dickinson and Company), 0.2% glycerol, 0.05% Tyloxapol (Sigma-Aldrich). Hygromycin B (50 μg/ml) was used as a selection marker for the fluorescent strain *smyc'::mCherry*. For mice infection, aliquots were frozen in 10% glycerol, titered and stored at −80°C until use, while fresh bacterial cultures were used for RNA extraction from tissue and broth cultures (reference samples).

### Mice {#S15}

C57BL/6J WT mice were purchased from The Jackson Laboratory. The mice used in this study were 6--8 weeks old. All mice were maintained in a specific pathogen free animal biosafety level 3 facility at Cornell University. Animal care was in accordance with the guidelines of the Association for Assessment and Accreditation of Laboratory Animal Care. All animal procedures were approved by the Institutional Animal Care and Use Committee of Cornell University.

METHOD DETAILS {#S16}
--------------

### BMDM culture and infection {#S17}

BMDM cells were isolated from femur and tibia of euthanized C57BL/6J WT mice (Jackson Laboratories). Briefly, femur and tibia were dissected from the mice and surrounding tissues and muscles removed. Both ends of the bones were cut, bone-marrow flushed with Dulbecco's modified Eagle's medium (DMEM) using a 21-gage needle, then centrifuged at 1000 rpm for 5′ and resuspended in DMEM supplemented with 10% fetal bovine serum (Thermo Scientific), 2 mM L-glutamine, 1 mM sodium pyruvate, 10% L-cell conditioning media and 1% penicillin/streptomycin (Corning cellgro). Cells were then grown at 37°C for 7 days in culture dishes while media was replenished every 3 days. At day 7, non-adherent cells together with red blood cells were removed using PBS washes. BMDM were infected with Mtb *smyc'::mCherry* at a multiplicity of infection of 2:1 for 4 hours (test samples) or 6 hours (reference samples). Briefly, macrophages were seeded in T75 vented tissue culture flasks at a density of \~2×10^7^ per flask. The next day, mid-log phase Mtb cultures (OD600 = 0.5 to 0.6) were harvested by centrifugation, resuspended in basal uptake buffer (PBS with 4.5 mg/ml glucose, 5 mg/ml BSA, 0.1 mg/ml CaCl~2~, 0.1 mg/ml MgCl~2~, and 1 mg/ml gelatin), passaged 10 times through a 21-gauge needle, and then used to infect macrophages. Extracellular bacteria were removed after 2 hours and the media replaced. At 4h or 6h post-infection, RNA was extracted as described in the corresponding sections of this paper.

### Mice infection and lung cells isolation {#S18}

Mice were infected intranasally with Mtb. Mice were anesthetized and inoculated with \~1000 CFU of the Erdman strain *smyc':: mCherry*, resuspended in 25ul of PBS containing 0.05% Tween 80. Inoculum dosage was confirmed by plating different dilutions of the bacterial stock in 7H10 agar plates supplemented with OADC, glycerol and hygromycin B. Plates were incubated at 37°C and colonies enumerated 3 weeks after. Two weeks post-infection mice were sacrificed, the lungs aseptically removed and placed in PBS containing 5% FBS. To minimize unwanted changes in the gene expression profile of both host and bacteria, samples were kept on ice and immediately processed using a GentleMACS tissue dissociator (Miltenyi Biotec). The dissociated lung material was then passed through a 70 μM cell strainer and red blood cells were lysed with ACK lysis buffer (Lonza).

### Sorting of AM and IM populations {#S19}

Staining of the lung phagocytes was streamlined to minimize processing time and unwanted changes in the gene expression profile. Briefly, lung cell suspensions were incubated for 20 minutes in the dark with fluorophore-conjugated antibodies against mouse CD64 (X54--5/7.1), MerTK (DS5MMER) and SiglecF (E50--2440) from BioLegend, Thermo Fisher or BD Biosciences. The panel of antibodies used in this study to separate the two phagocytic lung populations has been described and validated in a previous study ([@R28]). Stained samples have then been washed in PBS, resuspended in sorting buffer (PBS, 5% FBS, 5mM EDTA, 25mM HEPES) and sorted according to the gating strategy depicted in [Figure 1A](#F1){ref-type="fig"}. Samples were maintained at 4°C during sorting and collected directly into Trizol (Ambion).

Recovery of Mtb-infected cells from the lung tissues for subsequent processing varied from 1.2 -- 2.5×10^4^ for AM and 2.5 -- 4×10^4^ for IM, and a full description of these samples and subsequent RNA yields is provided in [Table 1](#T1){ref-type="table"}. In those cases where the number of recovered infected cells were lower than 40k, we chose a trade-off between enrichment and sequencing depth in order to have enough input RNA for library preparation ([Figure 1D](#F1){ref-type="fig"}; [Table 1](#T1){ref-type="table"})

### Extracellular Flux Analysis (Agilent Seahorse) {#S20}

Real-time cell metabolism of AM and IM was determined by using a XFp Extracellular Flux Analyzer. FACS sorted AM and IM were plated in 8-well Seahorse plates. Mitochondrial function was determined by using the Seahorse XFp Cell Mito Stress Test Kit (Agilent Technologies, Santa Clara, CA), according to the manufacturer's instruction. Three or four measurements were obtained under basal conditions and after the sequential addition of oligomycin, FCCP, etomoxir and Rotenone/antimycin A.

### Development of the Dual RNA-seq protocol {#S21}

Previous experiments informed us that 4 × 10^4^ was the maximum number of infected AM recoverable following sorting from 3 pooled mouse lungs. Therefore, since the number of infected host cells and consequently the amount of total mixed RNA recovered from an *in vivo* infection was likely to be limited, we performed preliminary experiments to assess if a modified rRNA depletion step worked efficiently for low-input samples and if the amount of total RNA left after bacterial enrichment would be sufficient for library preparation: our library preparation kit (see "[Library preparation and sequencing](#S23){ref-type="sec"}") requires at least 2ng of input RNA after rRNA depletion. From previous experiments, we estimated to recover \~90ng of total RNA from 40k eukaryotic cells, which after rRNA subtraction (95% of total RNA) would result in \~5ng of input RNA. Therefore, we tested the protocol using 2 biological replicates of BMDM, infected with fluorescent Mtb Erdman *(smyc'::mCherry)* at an MOI of 2:1 for 4h. 4×10^4^ Mtb-infected cells were sorted, collected and incubated in Trizol to lyse the host macrophages ([Figure 1B](#F1){ref-type="fig"}). The samples were processed for RNA isolation as detailed in the following section, following removal of 30% and 50% of the volume of the supernatant containing host RNA. In both cases we were able to recover enough mRNA (after rRNA depletion) for library preparation and we achieved an enrichment where 5% or 9% of the total reads aligned to the Mtb reference genome when discarding 30% or 50% of the volume of Trizol containing host RNA, respectively. Moreover, the modified rRNA depletion step was able to efficiently deplete ribosomal RNA from all the samples ([Table S1](#SD1){ref-type="supplementary-material"}).

### RNA extraction {#S22}

Bacterial RNA extraction for reference samples (BMDM at 6h of infection and broth cultures) was performed using the protocol previously described ([@R65]). Extraction of total RNA (eukaryotic + bacterial) from lung phagocytic populations was performed using the modified protocol to optimize the pathogen/host RNA ratio.

In brief, sorted samples were collected in Trizol, mixed and incubated for 5 minutes at RT to allow complete dissociation of the nucleoprotein complexes of the host cells. Specimens were then centrifuged at max speed for 20' to pellet intact mycobacterial cells. \~80% of the Trizol (containing host RNA) was removed and placed in an RNase-free tube for later use. 0.1mm zirconia/silica beads (Biospec) together with fresh Trizol (\~400ul) were then added to the Mtb containing tube and bacilli were lysed using a BeadBeater. Subsequently, based on the number of sorted cells, a portion of the host RNA (usually \> 50% of the volume) was added back to the tube containing bacterial RNA, mixed and the extraction carried out following the Trizol protocol. ([@R13]). Because of the limited number of infected phagocytes recovered from the sorting procedure, we used Glycoblue (Invitrogen) during the precipitation step to maximize RNA recovery and have sufficient quantity for library preparation. RNA samples were resuspended in nuclease-free water (Ambion) and genomic DNA contamination removed using the commercially available Turbo-DNA free kit (Invitrogen).

### Library preparation and sequencing {#S23}

rRNA removal was performed using 50--100ng total RNA input and a modified protocol for the Ribo-Zero Epidemiology Gold rRNA removal kit (Illumina). Briefly, 90 μL bead stock was used per sample, together with 2 μL each of reaction buffer and removal solution in a 20 μL reaction volume, as detailed in the manufacturer's protocol. The rRNA-depleted samples were purified by precipitating the RNA. Sequencing libraries were generated using the NEB Next Ultra II Directional RNA Library Prep Kit for Illumina (New England Bio-Labs). Libraries were sequenced on a Next Seq 500 (Illumina) in multiple rounds until the desired sequencing depth for bacterial reads was reached (target 1M 85nt reads).

QUANTIFICATION AND STATISTICAL ANALYSIS {#S24}
---------------------------------------

### Rationale for the use of APEGLM -- Approximate posterior estimation for generalized linear models {#S25}

Estimation of LFC (log fold change) represents a continuing challenge for RNA-seq analysis of datasets with low sequencing depth and limited numbers of biological replicates. In presence of low or high variable counts, the maximum likelihood estimates (MLE) for the LFCs have high variance leading to poor ranking of genes by effect sizes. Because ranking of genes by LFC is a common approach in the analysis of transcriptional data and ranked lists of genes are used in downstream applications such as network and pathway analysis, different approaches have been proposed to stabilize the estimation of LFC for genes with low counts and high variance, including filtering out low count genes and using scaled pseudocounts (edgeR, limma-voom) or through the use of Bayesian modeling. For example DESeq2, one of the most popular packages for differential gene expression analysis, ([@R41]) uses an adaptive normally distributed prior for shrinkage of LFC.

However recently, a new empirical Bayes procedure (APEGLM) that makes use of a heavy-tailed Cauchy prior distribution has been proposed to stabilize the estimator of LFC. ([@R89]) Briefly, using the same framework of DESeq2 (a Negative Binomial (NB) generalized linear model (GLM)), apeglm exchanges the normal distribution with a heavy-tailed Cauchy distribution on the effect sizes, with fixed shape and scale adapted to the distribution of observed MLE of the effect sizes for all genes. For each gene, it then uses a LaPlace approximation to provide shrinkage estimates and corresponding SD ([@R89]), This removes the needs for filtering rules or pseudocounts and maximizes the power of the current data to estimate the effect size for each gene. In particular, it has been shown that this statistical approach preserves true, large differences in LFC across conditions and is superior to common methods in ranking of genes by LFC in presence of low counts ([@R89]).

### Dual RNA-seq Data analysis {#S26}

Raw sequencing reads were analyzed using FastQC (v. 0.11.5) for quality control. Flexbar (v. 3.4)([@R64]) has been used to remove low quality reads and trim Illumina adapters. rRNA reads have been removed using Bowtie2 ([@R37]) (--sensitive mode) and a custom GTF file. For the processing of *in vivo* datasets, filtered fastq files were split using Bowtie2 (--very-sensitive mode) into species-specific files using the two reference genomes, GRCm38.94 for *Mus musculus* and NCBI assembly GCA_00668235.1 for Mtb Erdman. Hisat2 (v. 2.1.0) ([@R33]) was used to align reads to the respective transcriptomes and raw read counts for each sample were obtained using HTSeq (v. 0.11.0) ([@R5]). Two separate raw gene-count matrixes were obtained: one for the Mtb samples and one for the *Mus musculus* samples. Unless noted, exploratory, visualization and differential gene expression analysis was carried out in R using the DeSeq2 pipeline and APEGLM for LFC estimation. Genes with less than 10 raw counts across all samples were excluded from downstream analysis.

Pathway enrichment analysis was performed to compare the host conditions (AM versus IM, Infected versus Uninfected). A ranked list of genes was generated and GSEA analysis performed using the gene-sets provided by the BaderLab (<http://download.baderlab.org/EM_Genesets/>) excluding electronically annotated gene-sets. As of December 2018 this list contained around 26000 pathways from different sources (GO, Reactome, Panther, IOB, NetPath) ([@R60]). GSEA analysis was carried out with the following settings: 1) number of permutations: 2000; 2) Enrichment statistic: weighted; 3) Min and max gen-sets size: 10 and 500; 4) Normalization mode: meandiv. Gene-sets enriched in both populations at a nominal p value \< 0.01 were selected to build an Enrichment Map in Cytoscape ([@R45]; [@R60]). Because of the technical differences in the mRNA enrichment strategy between infected (rRNA depletion) and uninfected (polyA selection - [@R28]) samples, for the host cell infected versus uninfected comparisons ([Table S5](#SD4){ref-type="supplementary-material"}) genes known to be non-polyadenylated have been excluded from the downstream analysis with GSEA and Cytoscape. The protein-protein interaction network for the Mtb "in vivo signature" was created in Cytoscape using the STRING app (1.4.1). Only high-confidence interactions (co-expression, experiments, neighborhood, co-occurrence with a score \> 0.7) relative to query proteins were considered. The entire data pipeline (Linux commands, software settings and R code) is provided in [Supplementary Materials](#SD1){ref-type="supplementary-material"}.

### Data mining to define the Mtb *in vivo* gene-signature {#S27}

Using our own datasets (14 days AM and IM *in vivo*, 6hr BMDM cultures and 7H9-OADC broth cultures) we performed differential gene expression to identify a list of 274 genes that were specifically upregulated in one or both *in vivo* host macrophage populations (IM and AM) but not in either short-term BMDM or broth culture conditions. After that, we mined the microarray datasets from previous studies ([@R65]; [@R73]) to generate another list of genes that have been reported to be specifically upregulated in BMDM cultures (at different time points -- 24h, 48h up to 14 days of cell culture infection in the [@R65], or under different conditions -- activated versus resting BMDM in [@R73]) but not in broth cultures (7H9-OADC). Finally, we compared our 274 gene-list with this microarray-derived list and all the genes that overlapped were excluded from the "in vivo signature." We ended up with 180 genes specific to the *in vivo* infection environment. This certainly represents a conservative approach, however it allowed us to identify Mtb expression signatures unique to the *in vivo* lung macrophage environment.

### Statistical Analysis {#S28}

Statistical testing for the differential gene expression analysis (DGE) was performed as described ([@R41]). Shrinkage of effect sizes (LFC estimates) has been performed using the APEGLM method ([@R89]). Unless specified otherwise, genes having a false discovery rate (FDR) \< 0.05 and a fold change \> 1.5 were considered significant. Visualization and clustering (PCA, heatmaps of sample-to-sample distances) were performed on variance stabilized counts (vst) ([@R4]) with the option "blind = TRUE" in the DESeq2 package in order to compare samples in an unbiased manner. Heat-maps for specific groups of genes were generated using the normalized counts obtained from the DESeq2 analysis, which have been log-transformed and Z-scaled using the package heatmap2 in R.

DATA AND CODE AVAILABILITY {#S29}
--------------------------

The datasets supporting the conclusions of this article are available in GEO: GSE132354 <https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE132354>

The data analysis pipeline (Linux code and R scripts) is provided as a zip file in the [supplemental materials](#SD1){ref-type="supplementary-material"}.

The datasets for the uninfected AM and IM samples are available in GEO: GSE108844 <https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108844>

Supplementary Material {#SM1}
======================
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![*In Vivo* Dual RNA-Seq Pipeline for the Enrichment of Bacterial RNA from Flow-Sorted Lung Macrophages\
(A) Flow gating strategy used to identify the two different lung macrophages lineages. CD64^+^ and MerTk^+^ macrophages were separated from the rest of the immune population and the AM and IM lineages identified by the level of expression of Siglec*f*. IM- and AM-infected macrophages constituted \~9% and \~2%, respectively, of the total macrophage population. The experimental infection and cellular isolation was repeated three times independently (n = 3), each time pooling and processing lung tissue from three infected mice.\
(B) Diagram of the RNA extraction process. Samples were sorted in Trizol to release host RNA and pelleted, and the supernatant (containing most of the host RNA) was removed and placed aside. Fresh Trizol was added to the tube containing the bacterial pellet, and the bacteria were disrupted through mechanical lysis. A percentage of the host RNA (nominally 50%) was then transferred back to the tube containing the lysed bacteria and the resulting total RNA, now enriched for bacterial transcripts, processed following the Trizol protocol.\
(C) Example of an Agilent Bioanalyzer 2100 plot shows how physical separation of the host RNA from the bacterial pellet prior Mtb homogenization preserves RNA quality and integrity, as evidenced by the intact rRNA peaks and higher quality score (RNA quality number \[RQN\] 7.5 versus 4.8).\
(D) Bar chart illustrating the percentage of total reads that map to the Mtb Erdman genome for the test and *in vivo* samples.\
(E) Venn diagram showing the overlap of the genes (*abs*\[log~2~ FC \> 1\], false discovery rate \[FDR\] \< 0.05) detected as differentially expressed on the full reference datasets by DESeq2, IHW, edgeR, and limma-voom. We nominally defined this set of genes as "true DE."\
(F) Percentage of false positives (genes detected as differentially expressed; *abs*\[log~2~ FC \> 1\], FDR \< 0.05) in the subset of 1 M reads but not part of "true DE") for the most common used statistical approaches in RNA-seq analysis. APEGLM outperformed all other methods, with a false-positive rate of \<3.5%. p values were calculated using one-way ANOVA followed by Tukey's post hoc test.](nihms-1549887-f0002){#F1}

![Identification of an Mtb *In Vivo* Signature in Mice\
(A) Principal-component analysis (PCA) of the Mtb transcriptome from three different environmental conditions: *in vivo*, cell culture (BMDM), and broth (7H9-OADC).\
(B) Heatmap showing relative expression levels for the "*in vivo* signature," a set of 180 genes upregulated only during growth in lung macrophages.\
(C) Functional characterization of the *in vivo* gene signature shows how many of the genes belong to the "conserved hypothetical" class with undefined function.\
(D) Protein-protein network analysis of the "*in vivo* signature" reveals a cluster of genes involved in cholesterol degradation (*Kstr2*), response to nitrosative and oxidative stresses (ergothioneine), and nitrogen assimilation and export machinery (*Esx-5*). Only high-confidence (\>0.7) interactions were used to build the network.\
(E) Heatmap showing relative expression levels for the genes in the cholesterol degradation pathway Kstr2.\
(F) Boxplot of the main genes related to the MMP (*MutA, MutB*) and MCC (*PrpC, PrpD*) pathways. The transcriptional profile of Mtb from *in vivo* samples shows upregulation of the genes related to the MMP pathway but not of those involved in the recycling of the propionyl-CoA pool through the MCC.\
(G and H) Heatmaps showing relative expression levels for genes in the inorganic nitrogen (G) and ESX-5 (H) pathways in Mtb.\
(I) Violin plots showing expression levels (in log-normalized counts) of genes involved in the ergothioneine biosynthesis pathway.\
Where appropriate, for all plots the statistical significance is shown on the picture (\*adjusted p value \[p-adj.\] \< 0.05, \*\*p-adj. \< 0.01, \*\*\*p-adj. \< 0.001, and \*\*\*\*p-adj. \< 0.0001). q values for comparisons among the groups were calculated using the Wald test as implemented in the DESeq2 pipeline.](nihms-1549887-f0003){#F2}

![Analysis of Different Host-Pathogen Transcriptional Patterns in Mtb-Infected and Uninfected AMs and IMs\
(A) MA plot for the transcriptome of Mtb in the AM and IM lineages. The top 50 genes ordered by log~2~ fold change are highlighted. Genes with adjusted p \< 0.05 are considered statistically significant.\
(B) Volcano plot showing differential expression of macrophage genes in the IM- and AM-infected populations. The top 50 genes ordered by p-adj. are shown. Genes with FDRs \< 0.05 are considered statistically significant.\
(C) Heatmap showing relative expression levels of monocyte and AM-lineage-associated genes.\
(D) PCA comparing the transcriptomes of the macrophage populations. A clear separation between ontologically linked (PC1) and infection-associated (PC2) responses is observed.\
(E) Enrichment map comparing pathways upregulated in infected AMs versus infected IMs. Only GSEA gene sets with enrichment p values \< 0.01 were considered in the network.](nihms-1549887-f0004){#F3}

![Identification of Host and Bacterial Transcriptional Responses in Mtb Growth-Permissive AMs\
(A) Boxplots showing relative expression levels (in log-normalized counts) of genes involved in cholesterol and triglyceride metabolism in the host and genes involved in lipid import, degradation, and biosynthesis in Mtb. Our dataset reveals a transcriptional signature correlated with high availability of lipid carbon sources for the bacteria in AM and consequent use of these nutrients by Mtb during growth in this macrophage lineage.\
(B) Enrichment map comparing pathways upregulated in infected versus uninfected AMs.\
(C) Heatmap showing relative expression levels for the genes in the NRF2-oxidative stress response pathway.\
(D) Extracellular flux analysis on AMs and IMs sorted from the mouse lung after 2 weeks of infection with 10^3^ Mtb. (I) Oxygen consumption rate (OCR) was measured using the Cell Mito Stress Test Kit (Agilent). Oligo, oligomycin; FCCP, fluoro-carbonyl cyanide phenylhydrazone; eto, etomoxir; Rot/AA, rotenone and antimycin A. (II) Spare respiratory capacity (SRC) was calculated by normalizing maximum OCR to the basal level. (III) Reduction of maximum OCR after injection of etomoxir (Eto), a fatty acid oxidation inhibitor. p values were calculated using Student's t test.\
(E) (I) GSEA enrichment plot of infected versus uninfected AM for the "organic acid transport" pathway. (II) Boxplots showing relative expression levels (in log-normalized counts) of genes involved in the transport of molecules needed to prevent inflammation-associated intracellular damages: *Slc7A11*, which promotes cystine uptake and glutathione biosynthesis ([@R7]), and *Abcc1*, involved in the extrusion of reduced glutathione ([@R14]).\
Unless otherwise specified, the statistical significance is provided for each plot (\*p-adj. \< 0.05, \*\*p-adj. \< 0.01, \*\*\*p-adj. \< 0.001, and \*\*\*\*p-adj. \< 0.0001). q values for comparisons among the groups were calculated using the Wald test as implemented in the DESeq2 pipeline.](nihms-1549887-f0005){#F4}

![Transcriptional Signatures Specific to Mtb in AM and Enrichment map for the Infected versus Uninfected IMs\
(A) (I) Heatmaps showing relative expression levels for genes related to cell growth and division, ribosomal protein synthesis, cell wall synthesis, and TCA cycle and beta oxidation pathways for Mtb in AM. (II) Boxplots showing the expression levels (in log normalized counts) of the *sigD* and anti-sigma factor *sigD* (*rv3413c*) in Mtb.\
(B) Enrichment map comparing pathways upregulated in infected versus uninfected IMs. Only GSEA gene sets with enrichment p values \< 0.01 were considered in building the network.\
(C) Violin plots showing the expression levels (in log-normalized counts) of the host genes *Nos2* and *Hif1a*.\
Statistical significance is provided for each plot (\*p-adj. \< 0.05, \*\*p-adj. \< 0.01, \*\*\*p-adj. \< 0.001, and \*\*\*\*p-adj. \< 0.0001). q values for comparisons among the groups were calculated using the Wald test as implemented in the DESeq2 pipeline.](nihms-1549887-f0006){#F5}

![Transcriptional Signatures Specific to Mtb in IMs and Iron Metabolism\
(A) (I) Boxplots showing the expression levels (in log-normalized counts) of genes related to the *dosR* operon and HigA1 toxin/antitoxin system. (II) Heatmap showing the relative expression levels of genes involved in DNA repair and protein-folding processes in Mtb. (III) Violin plots showing the relative expression levels (in log-normalized counts) of the *hspX* and *ppe37* genes for Mtb in the AM and IM lineages.\
(B) Heatmaps showing the relative expression levels of iron-related genes in both the host and Mtb. The divergent transcriptional response to iron metabolism in the AM and IM populations correlate with a different iron-response phenotype in Mtb.\
(C) Boxplot showing the expression levels (in log-normalized counts) of the host *Nramp1* gene involved in the transport of iron into the cytoplasm and suppression of bacterial growth.\
(D) Boxplots showing the expression levels (in log-normalized counts) of the Mtb genes *irtA, mbtN*, and *eccA3*, involved in carboxymycobactin uptake, synthesis, and ESX-3 secretion system ([@R74]), respectively.\
Where appropriate, statistical significance is associated with each plot (\*p-adj. \< 0.05, \*\*p-adj. \< 0.01, \*\*\*p-adj. \< 0.001, and \*\*\*\*p-adj. \< 0.0001). q values for comparisons among the groups were calculated using the Wald test as implemented in the DESeq2 pipeline.](nihms-1549887-f0007){#F6}

###### 

Number of Reads for Each Sample that Match rRNA or Either One of the Two Organisms' Genomes

  Sample                        Raw Reads   rRNA (*Mtb* + Mouse)   Mouse   *M. tuberculosis*                  
  ----------------------------- ----------- ---------------------- ------- ------------------- ----- -------- -------
  AM 1 ∼25,000 infected cells   131.5 M     19.5 M                 14.8%   96.2 M              73%   1.2 M    0.9%
  AM 2 ∼18,000 infected cells   176.5 M     41.1 M                 23.3%   96.6 M              55%   1.3 M    0.75%
  AM 3 ∼12,000 infected cells   309.8 M     107.7 M                34.8%   51.4 M              17%   0.95 M   0.3%
  IM 1 ∼25,000 infected cells   140.6 M     15.3 M                 10.9%   72 M                51%   1.2 M    0.85%
  IM 2 ∼40,000 infected cells   47.5 M      6.6 M                  13.9%   33.2 M              70%   0.9 M    1.9%
  IM 3 ∼35,000 infected cells   83.7 M      12.2 M                 14.6%   54.3 M              65%   1 M      1.2%
  Mtb broth 1                   12.1 M      1.8 M                  14.7%   --                  --    10 M     83%
  Mtb broth 2                   13.7 M      1.4 M                  10.4%   --                  --    12 M     87.5%
  Mtb broth3                    15.1 M      0.8 M                  5.4%    --                  --    12.4 M   82%
  Mtb -- BMDM 1                 32.6 M      0.08 M                 0.25%   --                  --    28.5 M   87%
  Mtb -- BMDM 2                 35 M        0.11 M                 0.31%   --                  --    31.6 M   90%
  Mtb -- BMDM 3                 25.5 M      0.11 M                 0.47%   --                  --    23.6 M   93%

For the *in vivo* samples, the number of sorted cells is reported in the "Sample" column. As a result of the difference in the number of infected cells between AMs and IMs at 14 days post-infection, a lower bacterial RNA enrichment and higher sequencing depth were preferred in some AM samples to compensate for the reduced RNA yield.

  REAGENT or RESOURCE                              SOURCE                                                                                IDENTIFIER
  ------------------------------------------------ ------------------------------------------------------------------------------------- ----------------------------------------
  Antibodies                                                                                                                             
  CD64                                             Biolegend                                                                             Cat\# 139307, RRID:AB_2561962
  Mertk                                            Thermo Fisher                                                                         Cat\# 12--5751--82, RRID:AB_257262
  SiglecF                                          BD Bioscience                                                                         Cat\# 564514, RRID:AB_2738833
  Bacterial and Virus Strains                                                                                                            
  M.tuberculosis Erdman mCherry                    Originally from Tanya Parish lab <https://dx.plos.org/10.1371/journal.pone.0009823>   N/A
  Critical Commercial Assays                                                                                                             
  Ribo-Zero Gold rRNA Removal Kit (Epidemiology)   Illumina                                                                              Cat\# MRZE724
  Glycoblue                                        Thermo Fisher                                                                         Cat\# AM9515
  Seahorse XFp Cell Mito Stress Test Kit           Agilent                                                                               Cat\# 103010--100
  Deposited Data                                                                                                                         
  Bystander AM and IM populations                  GEO: GSE108844                                                                        N/A
  MicroArray studies                               [@R65]; [@R73]                                                                        N/A
  Experimental Models: Organisms/Strains                                                                                                 
  C57BL/6J mice                                    The Jackson Laboratory                                                                Cat\# JAX:000664, RRID:IMSR_JAX:000664
  Software and Algorithms                                                                                                                
  DESeq2                                           [@R41]                                                                                N/A
  ApeGLM                                           [@R89]                                                                                N/A
  GSEA                                             Broad Institute <http://software.broadinstitute.org/gsea/index.jsp>                   N/A
  EnrichmentMap                                    [@R60]                                                                                N/A
  FastQC (v. 0.11.5)                               <https://www.bioinformatics.babraham.ac.uk/projects/fastqc/>                          N/A
  Flexbar (v. 3.4)                                 [@R64]                                                                                N/A
  Bowtie2                                          [@R37]                                                                                N/A
  Hisat2 (v. 2.1.0)                                [@R33]                                                                                N/A
  HTSeq (v. 0.11.0)                                [@R5]                                                                                 N/A

-   Dual RNA-seq analysis of *M. tuberculosis* infected macrophages

-   Infected macrophages were isolated directly from mouse lung

-   Transcriptional signatures of host and pathogen varied with macrophage ontogeny

-   Data highlighted a key role for nutritional immunity in limiting bacterial growth

[^1]: AUTHOR CONTRIBUTIONS

    D.P., L.H., and D.G.R. designed the study. D.P. and L.H. conducted experiments. D.P., L.H., J.K.G., and D.G.R. analyzed and interpreted the results. D.P., L.H., and D.G.R. drafted and edited the manuscript.
